MedTrace Logo

In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy

NCT07218120 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-10-17

No results posted yet for this study

Summary

Women, older adults, individuals from communities of color, particularly Black and Latino persons, and individuals with lower socioeconomic status are historically underrepresented in clinical research. This is true across a range of clinical areas but no more so than in Alzheimer's Disease Research. The purpose of this study is to assess whether offering small $25 financial incentives can increase enrollment of diverse community members to the Alzheimer's Prevention Trial (APT) Webstudy, a memory concerns registry meant to accelerate clinical trials, relative to non-monetary incentives such as a reusable grocery bag. To do this we will test in-person recruitment efforts at community events and locations, such as Northgate Gonzalez Market locations and local food bank events. We also aim to compare the relative cost of recruiting an additional person to the APT Webstudy.

Conditions

  • Memory Decline
  • Healthy Subjects

Interventions

OTHER

Financial Incentive

$25 gift card

OTHER

Active Comparator #1

Nominal value gift

Sponsors & Collaborators

  • Vision y Compromiso

    collaborator UNKNOWN

  • Alzheimer's Therapeutic Research Institute

    collaborator OTHER

  • University of Southern California

    lead OTHER

Principal Investigators

  • Mireille Jaocbson, PhD · University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-09
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07218120 on ClinicalTrials.gov